Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TPM4
REST API REST API
Homo sapiens
TPM4 is differentially expressed in 259 experiments: 128 organism parts: liver, adipose tissue, ... (126 more);, 153 disease states: normal, acute promyelocytic leukemia, ... (151 more);, 84 cell types 166 cell lines 36 compound treatments and 69 other conditions.
Orthologs TPM1 (Saccharomyces cerevisiae)   Tpm4 (Mus musculus)   Tpm4 (Rattus norvegicus)   A6QR15_BOVIN (Bos taurus)   TPM2 (Saccharomyces cerevisiae)   Tm2 (Drosophila melanogaster)   Tm1 (Drosophila melanogaster)   tpm4 (Xenopus laevis)   TPM4 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, response to oxidative stress, cytoskeleton, structural constituent of muscle, cytoplasm, cellular component movement, cortical cytoskeleton, muscle contraction, calcium ion binding, filamentous actin, actin binding, stress fiber, muscle filament sliding, podosome, muscle thin filament tropomyosin
InterPro Term Tropomyosin
UniProt Accession P67936, B4DVY2
Search EB-eye ENSG00000167460
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-7540, E-GEOD-3526, E-MTAB-62, ... (25 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, ... (33 experiments)

Factor Value U/D Experiments
DU145
2
E-GEOD-17482, E-GEOD-20089
MCF-7
2
E-GEOD-19639, E-GEOD-3529
PC3
2
E-MEXP-2034, E-GEOD-5258
mcf7-lmo4-tetoff cells
1
E-MTAB-62
H1819
1
E-MTAB-62
MKN1
1
E-GEOD-15460
160 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-MEXP-66, E-GEOD-4219, E-GEOD-13909, ... (39 experiments)

Factor Value U/D Experiments
CD71+ early erythroid
2
E-AFMX-5, E-TABM-145
CD4+ T cell
1
2
E-GEOD-16190, E-AFMX-5, E-MTAB-25
immortalised T lymphocytes
1
E-GEOD-13909
BDCA4+ dentritic cells
1
E-AFMX-5
CD14+ monocyte
1
E-AFMX-5
M2 macrophage
1
E-GEOD-5099
78 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-TABM-15, E-MTAB-62, ... (54 experiments)

Factor Value U/D Experiments
control
3
E-GEOD-20602, E-GEOD-21912, E-GEOD-8121
glioblastoma
3
E-GEOD-6014, E-GEOD-4290, E-MTAB-62
prostate carcinoma
3
E-MEXP-2034, E-MTAB-62, E-GEOD-96
acute promyelocytic leukemia
1
3
E-GEOD-96, E-MTAB-62, E-GEOD-1729, E-GEOD-995
acute quadriplegic myopathy
2
E-MTAB-62, E-GEOD-3307
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
147 more value(s).


Compound treatment

studied in E-TABM-782, E-GEOD-5824, E-TABM-868, E-MEXP-1958, E-MEXP-941, ... (25 experiments)

Factor Value U/D Experiments
none
2
10
E-MEXP-1601, E-GEOD-5824, E-TABM-868, E-MEXP-1958, E-MEXP-1230, ... (12 experiments)
ethanol
2
E-MEXP-2241, E-GEOD-3113
control
2
E-GEOD-3284, E-GEOD-4006
lipopolysaccharide
2
E-TABM-868, E-MEXP-1958
ponasterone A
1
E-GEOD-3113
unknown
1
E-GEOD-7307
30 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-GEOD-1729

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, E-GEOD-1725, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-GEOD-6710, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-1614, E-GEOD-1638, E-MEXP-2359, E-MEXP-958, E-MTAB-62 ... (5 experiments)

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, E-TABM-147 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7011, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, E-MEXP-2340 ... (5 experiments)

Genotype
studied in E-GEOD-2466, E-GEOD-17476, E-GEOD-22593, E-TABM-868, E-TABM-601, ... (7 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-20540, E-GEOD-9764, E-MEXP-1741, E-TABM-440, E-MEXP-2146 ... (5 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-302, E-GEOD-21653

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-740, E-GEOD-2466, E-GEOD-1926, ... (25 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-9723

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-AFMX-1, E-GEOD-426

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-26495, E-GEOD-19703, E-GEOD-1657, E-GEOD-1460

Population
studied in E-MTAB-197, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-548, E-MEXP-1857, E-MEXP-1315, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-MEXP-70, E-GEOD-17400

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

targeted_cell_type
studied in E-MEXP-70

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-33562, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-1561

Vehicle
studied in E-GEOD-5258

Processing time: 0.44 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM